Overexpression of lncRNA SNGH3 Predicts Unfavorable Prognosis and Clinical Outcomes in Human Cancers: Evidence from a Meta-Analysis

Table 3

Association between overexpression lncRNA SNHG3 and clinical parameters.

Clinicopathologic parameters	No. of studies	No. of patients	OR	95% CL	(%)		Model
Age	9	655	1.03	0.74-1.44	0.0	0.545	Fixed
Gender	8	589	1.06	0.92-1.21	0.0	0.686	Fixed
Clinical stage	8	556	3.25	2.23-4.73	15.9	0.305	Fixed
Tumor size	7	553	1.86	0.71-4.87	76.7	0.0	Random
Lymph node metastasis	5	262	8.96	4.82-16.68	19.6	0.29	Fixed
Distant metastasis	3	323	2.18	1.05-4.52	31.4	0.233	Fixed
Histological grade	4	472	2.23	1.47-3.37	45.4	0.103	Fixed